| API Name | Therapeutic Category | DMF（Drug Mater File） |
| Abiraterone Acetate | Oncology | EU,US,CANADA,CHINA,JAPAN, BRAZIL |
| Apalutamide | Oncology | Q1 2024 |
| Bempedoic Acid | LDL-C | EU, US, CHINA |
| Betamethasone Valerate | Anti-inflammatory | EU(CEP), CANADA |
| Brivaracetam | Anti-epileptic | EU, US, CANADA, CHINA |
| Budesonide | Asthma | Q4 2024 |
| Elagolix | Endometriosis | EU, US |
| Enzalutamide | Oncology | EU, US, CHINA |
| Eplerenone | Hypertension | EU(CEP), US, CANADA, JAPAN |
| Finerenone | CKD | Q4 2024 (NCE-1 09 Jul 2025) |
| Dydrogesterone | Progestogen | EU(CEP), US, CHINA |
| Semaglutide | Type II diabetic | US |
| Fluticasone Propionate | Anti-allergic/ Asthma | EU(CEP), US, CHINA |
| Fluticasone Furoate | Anti-allergic/ Asthma | EU(CEP), US, CHINA |
| Mometasone Furoate | Anti-allergic/Anti inflammatory | EU(CEP), US |
| Nusinersen (ASO, Oligonucleotides) | Spinal Muscular Atrophy(SMA) | Q1 2024 |
| Pregabalin | Anti-epileptic | EU(CEP), US, CANADA, CHINA |
| Relugolix | Endometriosis | Q2, 2024 |
| TDF (Tenofovir Disoproxil Fumarate) | Anti-retrovirus, ARV | EU, US, CHINA |
| TAF (Tenofovir Alafenamide Hemifumarate) | Anti-retrovirus, ARV | EU, US, CHINA |
| TMF(Tenofovir Alafenamide Monofumarate) | Anti-retrovirus, ARV | EU, US, CHINA |
| Vibegron | Overactive bladder (OAB) | Q2 2024 |